Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. India
  4. NSE India Stock Exchange
  5. Gland Pharma Limited
  6. Summary
    GLAND   INE068V01023

GLAND PHARMA LIMITED

(GLAND)
  Report
Delayed NSE India Stock Exchange  -  06:25 2022-11-30 am EST
1779.65 INR   -5.23%
11/29Gland Pharma : Recording of Analysts/Institutional Investor Meet/Con. Call
PU
11/29Indian shares set for muted open ahead of GDP data
RE
11/29Gland Pharma to Acquire French Pharmaceutical Firm for $124 Million
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Days
:
Hours
:
Minutes
:
Seconds
Quotes 5-day view   Delayed Quote. Delayed Nse India Stock Exchange
11/24/2022 11/25/2022 11/28/2022 11/29/2022 11/30/2022 Date
1697.5(c) 1693.1(c) 1745.1(c) 1877.95(c) 1779.65 Last
135 568 98 764 150 780 3 084 728 1 689 301 Volume
-0.18% -0.26% +3.07% +7.61% -5.23% Change
More quotes
Estimated financial data (e)
Sales 2023 42 445 M 520 M 520 M
Net income 2023 10 806 M 132 M 132 M
Net cash position 2023 29 758 M 364 M 364 M
P/E ratio 2023 27,1x
Yield 2023 0,07%
Sales 2024 53 835 M 659 M 659 M
Net income 2024 14 077 M 172 M 172 M
Net cash position 2024 36 844 M 451 M 451 M
P/E ratio 2024 20,8x
Yield 2024 0,07%
Capitalization 293 B 3 589 M 3 589 M
EV / Sales 2023 6,20x
EV / Sales 2024 4,76x
Nbr of Employees 4 639
Free-Float 37,1%
More Financials
Company
Gland Pharma Limited is an India-based company that manufactures small volume parenterals (SVPs). The Company provides a range of injectables including vials, ampoules, pre-filled syringes, lyophilized vials, dry powders, infusions and ophthalmic solutions. It provides contract development and manufacturing services, such as evaluation of development needs, identifying application program interface (API) sources,... 
Sector
Pharmaceuticals
Calendar
01/20Earnings Release
More about the company
Ratings of Gland Pharma Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about GLAND PHARMA LIMITED
11/29Gland Pharma : Recording of Analysts/Institutional Investor Meet/Con. Call
PU
11/29Indian shares set for muted open ahead of GDP data
RE
11/29Gland Pharma to Acquire French Pharmaceutical Firm for $124 Million
MT
11/29India's Gland Pharma to buy Cenexi for $124 mln in Europe push
RE
11/29Transcript : Cenexi - Laboratoires Thissen SA, Gland Pharma Limited - M&A Cal..
CI
11/29India's Gland Pharma to buy France's Cenexi for $124 million
RE
11/29Fosun Reportedly Planning Sale of Gland Pharma
CI
11/29China's Fosun Reportedly Said to Mull Sale of India's $3.6 Billion Gland Pharma
CI
11/29Fosun weighs sale of Indian drugmaker Gland Pharma - Bloomberg News
RE
10/28Nomura Adjusts Gland Pharma's Price target to 2,236 Indian Rupees From 2,362 Rupees, Ke..
MT
10/28Gland Pharma : Schedule of Analysts/Institutional Investor Meet/Con. Call
PU
10/27Jefferies Downgrades Gland Pharma to Hold From Buy, Adjusts Price Target to 2,241 India..
MT
10/26Gland Pharma Posts Decline in Fiscal Q2 Consolidated Net Profit
MT
10/26Transcript : Gland Pharma Limited, Q2 2023 Earnings Call, Oct 26, 2022
CI
10/26Gland Pharma's Consolidated Profit Declines in Fiscal Q2
MT
More news
News in other languages on GLAND PHARMA LIMITED
11/29Les actions indiennes s'apprêtent à ouvrir en douceur avant les données sur le PIB.
11/29L'entreprise indienne Gland Pharma achète l'entreprise française Cenexi pour 124 millio..
11/29EN DIRECTO DESDE LOS MERCADOS: Merlin, ASM International, ..
11/29Bolsa de Madrid: Jay envía a sus Halcones a la caza
11/29Fosun envisagerait la vente de Gland Pharma
More news
Analyst Recommendations on GLAND PHARMA LIMITED
More recommendations
ETFs positioned on GLAND PHARMA LIMITEDETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
KraneShares Emerging Market Healthcare Inde...1.1%1.15%NC
Nippon India ETF Junior BeES - INR0.89%1.41%-India
SBI ETF NIFTY NEXT 50 - INR0.38%1.43%-India
Nippon India ETF Nifty 100 - INR0.14%1.30%-India
ICICI Prudential Nifty 100 iWIN ETF - INR0.13%1.92%-India
More ETFs positioned on GLAND PHARMA LIMITED
Chart GLAND PHARMA LIMITED
Duration : Period :
Gland Pharma Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GLAND PHARMA LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Last Close Price 1 779,65 INR
Average target price 2 585,50 INR
Spread / Average Target 45,3%
EPS Revisions
Managers and Directors
Srinivas Sadu CEO, Managing Director & Director
Ravi Shekhar Mitra Chief Financial Officer
Yiu Kwan Lau Independent Chairman
K. V. G. K. Raju Manager-Quality Control & Development
Surapanini Sridevi Senior Vice President-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
GLAND PHARMA LIMITED-51.41%3 788
JOHNSON & JOHNSON2.93%460 384
ELI LILLY AND COMPANY32.42%345 817
ABBVIE INC.16.84%279 679
PFIZER, INC.-16.19%277 803
NOVO NORDISK A/S19.71%276 497